AstronauTx appoints Jane Rhodes as Chief Executive Officer and Expands Executive Team
- Jane Rhodes appointed as Chief Executive Officer
- Magnus Ivarsson appointed as Chief Translation and Early Development Officer
London UK, 1 October 2024 – AstronauTx Ltd (“AstronauTx”), a biotechnology company developing novel treatments for Alzheimer’s disease and other neurodegenerative disorders, today announces the appointment of Dr Jane Rhodes, PhD, MBA, as Chief Executive Officer (CEO) and member of the Board, and Magnus Ivarsson as Chief Translation and Early Development Officer.
